Kristen Coppock Crossley, MA

The new service from Serenity Vet allows veterinary clinics and hospitals to manage relief staffing tasks with assistance from AI and automation

Lindsay Hallman, CVT, CCMT, VTS (Oncology), and Katelyn McDonald, CVT, VTS (Oncology), discuss clinical administration of oncology therapy, in a dvm360 interview.

Dion Small, BSc, LVT, found his passion for animal care and a purpose in leadership

The single-injection monoclonal antibody (Lenivia) from Zoetis reduces OA pain in dogs for 3 months.

Investigators with the Dog Aging Project assessed 1726 feeding plans created by pet owners.

Lindsay Hallman, CVT, CCMT, VTS (Oncology), and Katelyn McDonald, CVT, VTS (Oncology), discuss what oncology patients may experience in a dvm360 interview.

The new school at Clemson University aims to welcome its first students in fall 2026.

The highly contagious virus has been linked to a recent rodeo event, with known cases diagnosed in horses from Texas and Oklahoma.

Boehringer Ingelheim earned positive opinions for 2 immunization therapies in the pipeline.

OS Therapeutics' veterinary division is developing OST-HER2 for canine osteosarcoma treatment.

Lindsay Hallman, CVT, CCMT, VTS (Oncology) and Katelyn McDonald, CVT, VTS (Oncology), discuss methods for a calm administration and positive pet experience.

The program is used to combat New World screwworm, a global health threat.

The study results place the American foulbrood prevention therapy closer to full USDA licensure.

Zoetis’ Vanguard Recombishield is a nonadjuvanted, recombinant injectable therapy.

Dion Small, BSc, LVT, discusses one of the biggest challenges for veterinary technicians in a dvm360 interview.

Solovecin by Dechra is a generic antibiotic for the treatment of skin infections in dogs and cats.

The business, formerly known as SmartPak Equine, is currently owned by Covetrus.

Felixvet has announced the approval for a bioequivalent product to Simplicef (Zoetis).

Akston Biosciences Corporation partnered with Purdue University to develop a drug targeting PD-L1 in dogs with solid tumors.

Zoetis' relfovetmab product is a long-acting anti–nerve growth factor monoclonal therapy for cats.

The 2 drugs from Elanco now offer protection from emerging tick species and aid in the prevention of Lyme disease in canines.

Charlotte Weir discussed first impressions for clients and how workplace culture can empower staff in a Fetch dvm360 Conference presentation.

The new Assisi Loop Lounge provides pain relief and comfort to dogs, cats, rabbits and exotic animals.

Nancy Patsos, LVT, VTS (ECC), discusses unique issues and how practice leadership can help alleviate them.

The first Vet Tech Summit at the Elmwood Park Zoo in Pennsylvania was attended by more than 50 students from 3 area colleges.

The inaugural class for the new School of Veterinary Medicine graduated in May 2025.

Veterinary Technician Summit panelists at the Elmwood Park Zoo in Pennsylvania discuss opportunities outside small animal practice.

Arkansas State University celebrated the symbolic milestone in constructing its new facility during a celebratory event.

Zoetis' drug was recently approved in Canada and recommended in Europe.